Drugs / Titanium-Prepared Platelet-Rich Fibrin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06865092 | May 2023 → Nov 2025 | gingival overgrowth | University of Health Sciences | Completed | No outcome recorded |
| — | NCT07712497 | Mar → Dec 2023 | — | Eskisehir Osmangazi University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | titanium-prepared platelet-rich fibrin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06865092 ↗ |
| Known as | T-PRF | “Autologous titanium-prepared platelet-rich fibrin (T-PRF) was prepared from the participant's venous blood collected into sterile titanium tubes without anticoagulant and...” NCT07712497 ↗ |
| Route | Other | “placed into the extraction socket immediately after atraumatic tooth extraction” NCT07712497 ↗ |